pentetic acid has been researched along with Thyroid Neoplasms in 52 studies
Pentetic Acid: An iron chelating agent with properties like EDETIC ACID. DTPA has also been used as a chelator for other metals, such as plutonium.
Thyroid Neoplasms: Tumors or cancer of the THYROID GLAND.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Medullary thyroid cancer (MTC) is a rare but potentially life-threatening disease with limited therapeutic options." | 2.80 | Is there a role for peptide receptor radionuclide therapy in medullary thyroid cancer? ( Bulzico, DA; Carneiro, M; Corbo, R; de Carvalho Leal, D; Kendler, DB; Lopes, FP; Pessoa, CH; Rosado de Castro, PH; Vaisman, F; Vaisman, M; Vilhena, B, 2015) |
| "In one patient with widespread bone metastases, octreotide gave a more detailed assessment of metastatic disease than conventional radiology." | 2.71 | Indium-111-labelled octreotide scintigraphy in the diagnosis and management of non-iodine avid metastatic carcinoma of the thyroid. ( Christian, JA; Cook, GJ; Harmer, C, 2003) |
| "In patients with midgut carcinoids, (all scintigraphy positive), false Rin situ recordings were found in 4/29 macroscopically identified tumours." | 2.68 | Intraoperative detection of somatostatin-receptor-positive neuroendocrine tumours using indium-111-labelled DTPA-D-Phe1-octreotide. ( Ahlman, H; Fjalling, M; Forssell-Aronsson, E; Nilsson, O; Tisell, LE; Wangberg, B, 1996) |
| " Analysis of dose-response curves at days 20 and 40 showed additivity between RIT and paclitaxel, and analysis at day 60 suggested a synergistic effect." | 1.31 | Enhanced antitumor activity of combined pretargeted radioimmunotherapy and paclitaxel in medullary thyroid cancer xenograft. ( Barbet, J; Campion, L; Chatal, JF; Chérel, M; Faivre-Chauvet, A; Kraeber-Bodéré, F; Mirallié, E; Saï-Maurel, C; Supiot, S; Thédrez, P, 2002) |
| "The staging of metastatic medullary thyroid cancer (MTC) with the conventional radiological procedures is sometimes difficult." | 1.31 | Cholecystokinin-B (CCK-B)/gastrin receptor targeting peptides for staging and therapy of medullary thyroid cancer and other CCK-B receptor expressing malignancies. ( Béhé, M; Behr, TM, 2002) |
| "In order to detect recurrences or metastases, in conjunction with conventional imaging techniques (cervical and hepatic ultrasonography, lung CT scan." | 1.30 | [Value of scintigraphic explorations by radiomarkers others than iodine radioisotope in differentiated thyroid cancer]. ( Borson-Chazot, F; Houzard, C; Sassolas, G; Sigartau, C, 1997) |
| "Patients had a history of thyroid cancer or of carcinoid tumor." | 1.30 | Thoracic and abdominal SPECT-CT image fusion without external markers in endocrine carcinomas. The Group of Thyroid Tumoral Pathology of Champagne-Ardenne. ( Delisle, MJ; Liehn, JC; Pérault, C; Schvartz, C; Wampach, H, 1997) |
| "Patient 1 had a metastatic follicular thyroid carcinoma, patient 2 a metastatic medullary thyroid carcinoma, patient 3 tuberculosis and patient 4 an insulinoma." | 1.30 | Somatostatin receptor scintigraphy using [111In-DTPA0]RC-160 in humans: a comparison with [111In-DTPA0]octreotide. ( Breeman, WA; Krenning, EP; Kwekkeboom, DJ; van Hagen, PM; Visser, TJ, 1998) |
| "For midgut carcinoids, the tumor-to-blood ratio was 51:220, for medullary thyroid carcinoma 4:39, and for two endocrine pancreatic tumors 6 and 1500." | 1.29 | Indium-111 activity concentration in tissue samples after intravenous injection of indium-111-DTPA-D-Phe-1-octreotide. ( Ahlman, H; Fjälling, M; Forssell-Aronsson, E; Nilsson, O; Tisell, LE; Wängberg, B, 1995) |
| "In patients with carcinoids, a combination of somatostatin receptor scintigraphy, chest radiograph and ultrasound of the upper abdomen had a high sensitivity for tumor localization, and detected lesions in patients in whom no tumor was found with conventional imaging, justifying the greater cost." | 1.29 | Cost-effectiveness analysis of somatostatin receptor scintigraphy. ( Habbema, JD; Krenning, EP; Kwekkeboom, DJ; Lamberts, SW, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (3.85) | 18.7374 |
| 1990's | 29 (55.77) | 18.2507 |
| 2000's | 15 (28.85) | 29.6817 |
| 2010's | 6 (11.54) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beukhof, CM | 1 |
| Brabander, T | 1 |
| van Nederveen, FH | 1 |
| van Velthuysen, MF | 1 |
| de Rijke, YB | 1 |
| Hofland, LJ | 1 |
| Franssen, GJH | 1 |
| Fröberg, LAC | 1 |
| Kam, BLR | 1 |
| Visser, WE | 1 |
| de Herder, WW | 2 |
| Peeters, RP | 1 |
| Vaisman, F | 1 |
| Rosado de Castro, PH | 1 |
| Lopes, FP | 1 |
| Kendler, DB | 1 |
| Pessoa, CH | 1 |
| Bulzico, DA | 1 |
| de Carvalho Leal, D | 1 |
| Vilhena, B | 1 |
| Vaisman, M | 1 |
| Carneiro, M | 1 |
| Corbo, R | 1 |
| Wild, D | 1 |
| Fani, M | 1 |
| Behe, M | 3 |
| Brink, I | 1 |
| Rivier, JE | 1 |
| Reubi, JC | 3 |
| Maecke, HR | 2 |
| Weber, WA | 1 |
| Bomanji, JB | 1 |
| Papathanasiou, ND | 1 |
| Salaun, PY | 1 |
| Campion, L | 5 |
| Bournaud, C | 1 |
| Faivre-Chauvet, A | 3 |
| Vuillez, JP | 3 |
| Taieb, D | 1 |
| Ansquer, C | 1 |
| Rousseau, C | 1 |
| Borson-Chazot, F | 2 |
| Bardet, S | 3 |
| Oudoux, A | 1 |
| Cariou, B | 1 |
| Mirallié, E | 2 |
| Chang, CH | 2 |
| Sharkey, RM | 2 |
| Goldenberg, DM | 2 |
| Chatal, JF | 6 |
| Barbet, J | 6 |
| Kraeber-Bodéré, F | 5 |
| Boubaker, A | 1 |
| Prior, JO | 1 |
| Willi, JP | 1 |
| Champendal, M | 1 |
| Kosinski, M | 1 |
| Bischof Delaloye, A | 1 |
| Ginj, M | 1 |
| Baechler, S | 1 |
| Buchegger, F | 1 |
| Saï-Maurel, C | 3 |
| Chérel, M | 1 |
| Supiot, S | 1 |
| Thédrez, P | 3 |
| Sarlis, NJ | 1 |
| Gourgiotis, L | 1 |
| Guthrie, LC | 1 |
| Galen, B | 1 |
| Skarulis, MC | 1 |
| Shawker, TH | 1 |
| Patronas, NJ | 1 |
| Reynolds, JC | 1 |
| Behr, TM | 2 |
| Becker, W | 1 |
| Gotthardt, M | 1 |
| Angerstein, C | 1 |
| Christian, JA | 1 |
| Cook, GJ | 1 |
| Harmer, C | 1 |
| Stokkel, MP | 1 |
| Verkooijen, RB | 1 |
| Bouwsma, H | 1 |
| Smit, JW | 1 |
| Gao, Z | 1 |
| Biersack, HJ | 2 |
| Ezziddin, S | 1 |
| Logvinski, T | 1 |
| An, R | 2 |
| Charbonnel, B | 1 |
| Rohmer, V | 1 |
| Gao, ZR | 1 |
| Zhang, YX | 1 |
| Berná, L | 1 |
| Cabezas, R | 1 |
| Mora, J | 1 |
| Torres, G | 1 |
| Estorch, M | 1 |
| Carrió, I | 1 |
| Eising, EG | 1 |
| Farahati, J | 1 |
| Bier, D | 1 |
| Knust, EJ | 1 |
| Reiners, C | 1 |
| Forssell-Aronsson, E | 4 |
| Fjälling, M | 4 |
| Nilsson, O | 5 |
| Tisell, LE | 5 |
| Wängberg, B | 5 |
| Ahlman, H | 5 |
| Dörr, U | 3 |
| Sautter-Bihl, ML | 1 |
| Bihl, H | 3 |
| Adrian, HJ | 1 |
| Bach, D | 1 |
| Würstlin, S | 1 |
| Frank-Raue, K | 1 |
| Raue, F | 1 |
| Hehrmann, R | 1 |
| Iser, G | 1 |
| Scholz, M | 1 |
| Guhl, L | 1 |
| Buhr, HJ | 1 |
| Arnberg, H | 1 |
| Westlin, JE | 1 |
| Husin, S | 1 |
| Nilsson, S | 1 |
| Baudin, E | 2 |
| Schlumberger, M | 2 |
| Lumbroso, J | 2 |
| Travagli, JP | 2 |
| Caillou, B | 1 |
| Parmentier, C | 2 |
| Kwekkeboom, DJ | 4 |
| Lamberts, SW | 1 |
| Habbema, JD | 1 |
| Krenning, EP | 5 |
| Leclere, J | 1 |
| Giammarile, F | 1 |
| Gardet, P | 1 |
| Roche, A | 1 |
| Postema, PT | 1 |
| Oei, HY | 1 |
| Bruining, HJ | 1 |
| Bonjer, J | 1 |
| van Toor, H | 1 |
| Hennemann, G | 1 |
| Kurtaran, A | 2 |
| Leimer, M | 1 |
| Kaserer, K | 2 |
| Yang, Q | 1 |
| Angelberger, P | 2 |
| Niederle, B | 2 |
| Virgolini, I | 2 |
| Nakahara, H | 1 |
| Noguchi, S | 1 |
| Murakami, N | 1 |
| Tamura, S | 1 |
| Jinnouchi, S | 1 |
| Kodama, T | 1 |
| Adjei, ON | 1 |
| Nagamachi, S | 1 |
| Ohnishi, T | 1 |
| Futami, S | 1 |
| Flores, LG | 1 |
| Watanabe, K | 1 |
| Hansson, G | 1 |
| Mölne, J | 3 |
| Lindstedt, G | 1 |
| Horn, JD | 1 |
| Gordon, BM | 1 |
| Gordon, L | 1 |
| Spicer, KM | 1 |
| Sassolas, G | 1 |
| Houzard, C | 1 |
| Sigartau, C | 1 |
| Pérault, C | 1 |
| Schvartz, C | 1 |
| Wampach, H | 1 |
| Liehn, JC | 1 |
| Delisle, MJ | 1 |
| Williams, JE | 1 |
| Adams, S | 1 |
| Baum, R | 1 |
| Rink, T | 1 |
| Schumm-Dräger, PM | 1 |
| Usadel, KH | 1 |
| Hör, G | 1 |
| Breeman, WA | 1 |
| van Hagen, PM | 1 |
| Visser, TJ | 2 |
| Gulec, SA | 1 |
| Serafini, AN | 1 |
| Sridhar, KS | 1 |
| Peker, KR | 1 |
| Gupta, A | 1 |
| Goodwin, WJ | 1 |
| Sfakianakis, GN | 1 |
| Moffat, FL | 1 |
| De Jong, M | 2 |
| Bernard, BF | 1 |
| De Bruin, E | 1 |
| Van Gameren, A | 1 |
| Bakker, WH | 2 |
| Mäcke, HR | 1 |
| Shi, W | 1 |
| Johnston, CF | 1 |
| Buchanan, KD | 1 |
| Ferguson, WR | 1 |
| Laird, JD | 1 |
| Crothers, JG | 1 |
| McIlrath, EM | 1 |
| Peltier, P | 1 |
| Bachelot, I | 1 |
| Denet, S | 1 |
| Olivier, P | 1 |
| Leccia, F | 1 |
| Corcuff, B | 1 |
| Huglo, D | 1 |
| Proye, C | 1 |
| Rouvier, E | 1 |
| Meyer, P | 1 |
| Scheuba, C | 1 |
| Schima, W | 1 |
| Czerny, C | 1 |
| Faibre-Chauvet, A | 1 |
| Gautherot, E | 2 |
| Fiche, M | 2 |
| Le Boterff, J | 2 |
| Kölby, L | 2 |
| Forssell-Aronsson, EB | 1 |
| Bejegård, SA | 1 |
| Bernhardt, P | 1 |
| Hashemi, SH | 1 |
| Kooij, PP | 1 |
| Erion, J | 1 |
| Srinivasan, A | 1 |
| Chu, DZ | 1 |
| Yamauchi, DM | 1 |
| Williams, LE | 1 |
| Liu, A | 1 |
| Wilczynski, S | 1 |
| Wu, AM | 1 |
| Shively, JE | 1 |
| Doroshow, JH | 1 |
| Raubitschek, AA | 1 |
| Banzo, J | 1 |
| Abós, MD | 1 |
| Prats, E | 1 |
| Delgado , M | 1 |
| Razola, P | 1 |
| García, S | 1 |
| Gomollón, F | 1 |
| García, F | 1 |
| Cuccurullo, V | 1 |
| Cascini, GL | 1 |
| Rambaldi, PF | 1 |
| Mansi, L | 1 |
| Colao, A | 1 |
| Dorato, M | 1 |
| Pulcrano, M | 1 |
| Rossi, FW | 1 |
| Auriemma, RS | 1 |
| Lombardi, G | 1 |
| Lastoria, S | 1 |
| Ceccarelli, C | 1 |
| Pacini, F | 1 |
| Lippi, F | 1 |
| Pinchera, A | 1 |
| Fischer, M | 1 |
| Hoffmann, UJ | 1 |
| Köhnlein, W | 1 |
| Skutta, D | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Pretargeted Radioimmunotherapy of Colorectal Cancer: A Phase I Study to Determine Dose-limiting Toxicity and Maximum Tolerated Dose of an Anti-CEACAM5 bsMAb-pretargeted 90Y-hapten-peptide[NCT01273402] | Phase 1 | 0 participants (Actual) | Interventional | 2011-02-28 | Withdrawn (stopped due to A new study is being designed. No patients were enrolled.) | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 reviews available for pentetic acid and Thyroid Neoplasms
| Article | Year |
|---|---|
¹¹¹In-DTPA⁰-octreotide (Octreoscan), ¹³¹I-MIBG and other agents for radionuclide therapy of NETs.
Topics: 3-Iodobenzylguanidine; Carcinoid Tumor; Carcinoma, Neuroendocrine; Humans; Iodine Radioisotopes; Neu | 2012 |
[Role of somatostatin analogs in the treatment of neuroendocrine tumours].
Topics: Adrenal Gland Neoplasms; Adrenalectomy; Antineoplastic Agents, Hormonal; Carcinoma, Medullary; Carci | 2001 |
[Somatostatin analogs in the clinical management of pituitary neoplasms].
Topics: Acromegaly; Adenoma; Adolescent; Adrenal Gland Neoplasms; Adult; Aged; Antineoplastic Agents, Hormon | 2001 |
15 trials available for pentetic acid and Thyroid Neoplasms
| Article | Year |
|---|---|
Is there a role for peptide receptor radionuclide therapy in medullary thyroid cancer?
Topics: Adult; Aged; Carcinoma, Neuroendocrine; Female; Humans; Male; Middle Aged; Octreotide; Organometalli | 2015 |
Phase II trial of anticarcinoembryonic antigen pretargeted radioimmunotherapy in progressive metastatic medullary thyroid carcinoma: biomarker response and survival improvement.
Topics: Adult; Aged; Aged, 80 and over; Animals; Antibodies, Bispecific; Antibodies, Monoclonal, Humanized; | 2012 |
In-111 DTPA-octreotide scintigraphy for disease detection in metastatic thyroid cancer: comparison with F-18 FDG positron emission tomography and extensive conventional radiographic imaging.
Topics: Bone Neoplasms; Carcinoma; Cohort Studies; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; | 2003 |
Improved kinetic stability of DTPA- dGlu as compared with conventional monofunctional DTPA in chelating indium and yttrium: preclinical and initial clinical evaluation of radiometal labelled minigastrin derivatives.
Topics: Animals; Carcinoma, Medullary; Cell Line, Tumor; Chelating Agents; Drug Evaluation, Preclinical; Dru | 2003 |
Indium-111-labelled octreotide scintigraphy in the diagnosis and management of non-iodine avid metastatic carcinoma of the thyroid.
Topics: Antineoplastic Agents, Hormonal; Bone Neoplasms; Chelating Agents; Humans; Indium Radioisotopes; Iod | 2003 |
Six month follow-up after 111In-DTPA-octreotide therapy in patients with progressive radioiodine non-responsive thyroid cancer: a pilot study.
Topics: Adult; Aged; Female; Follow-Up Studies; Humans; Iodine Radioisotopes; Male; Middle Aged; Octreotide; | 2004 |
The role of combined imaging in metastatic medullary thyroid carcinoma: 111In-DTPA-octreotide and 131I/123I-MIBG as predictors for radionuclide therapy.
Topics: 3-Iodobenzylguanidine; Adult; Carcinoma, Medullary; Female; Humans; Indium Radioisotopes; Iodine Rad | 2004 |
Survival improvement in patients with medullary thyroid carcinoma who undergo pretargeted anti-carcinoembryonic-antigen radioimmunotherapy: a collaborative study with the French Endocrine Tumor Group.
Topics: Antibodies, Monoclonal; Calcitonin; Humans; Indium; Pentetic Acid; Prognosis; Radioimmunotherapy; Su | 2006 |
[Targeted radionuclide therapy for patients with metastatic medullary thyroid carcinoma].
Topics: 3-Iodobenzylguanidine; Adult; Aged; Antineoplastic Agents; Carcinoma, Medullary; Female; Follow-Up S | 2006 |
Intraoperative detection of somatostatin-receptor-positive neuroendocrine tumours using indium-111-labelled DTPA-D-Phe1-octreotide.
Topics: Carcinoid Tumor; Female; Humans; Indium Radioisotopes; Intraoperative Care; Neuroendocrine Tumors; O | 1996 |
Somatostatin receptor scintigraphy in non-medullary thyroid cancer.
Topics: Carcinoma, Papillary; Carcinoma, Papillary, Follicular; Humans; Indium Radioisotopes; Neoplasm Metas | 1996 |
Combined use of 111In-DTPA-D-Phe-1-octreotide (OCT) and 123I-vasoactive intestinal peptide (VIP) in the localization diagnosis of medullary thyroid carcinoma (MTC).
Topics: Adult; Aged; Carcinoma, Medullary; Female; Humans; Indium Radioisotopes; Iodine Radioisotopes; Male; | 1996 |
Limited value of fluorine-18 fluorodeoxyglucose positron emission tomography for the imaging of neuroendocrine tumours.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Gastrointestinal Agents; Humans; Image Processing, Comp | 1998 |
Radioimmunodetection of medullary thyroid carcinoma using indium-111 bivalent hapten and anti-CEA x anti-DTPA-indium bispecific antibody.
Topics: Adult; Aged; Antibodies, Bispecific; Biomarkers, Tumor; Carcinoembryonic Antigen; Carcinoma, Medulla | 1998 |
A phase I radioimmunotherapy trial evaluating 90yttrium-labeled anti-carcinoembryonic antigen (CEA) chimeric T84.66 in patients with metastatic CEA-producing malignancies.
Topics: Animals; Antibodies, Monoclonal; Bone Marrow; Carcinoembryonic Antigen; Colorectal Neoplasms; Humans | 2000 |
34 other studies available for pentetic acid and Thyroid Neoplasms
| Article | Year |
|---|---|
Peptide receptor radionuclide therapy in patients with medullary thyroid carcinoma: predictors and pitfalls.
Topics: Adult; Aged; Carcinoma, Neuroendocrine; Feasibility Studies; Female; Humans; Male; Middle Aged; Octr | 2019 |
First clinical evidence that imaging with somatostatin receptor antagonists is feasible.
Topics: Aged; Coordination Complexes; Endocrine Gland Neoplasms; Feasibility Studies; Humans; Male; Middle A | 2011 |
Biokinetics and dosimetry of 111In-DOTA-NOC-ATE compared with 111In-DTPA-octreotide.
Topics: Adult; Aged; Carcinoma, Neuroendocrine; Female; Humans; Male; Middle Aged; Neuroendocrine Tumors; Oc | 2012 |
Enhanced antitumor activity of combined pretargeted radioimmunotherapy and paclitaxel in medullary thyroid cancer xenograft.
Topics: Animals; Antibodies, Bispecific; Carcinoembryonic Antigen; Carcinoma, Medullary; Combined Modality T | 2002 |
Cholecystokinin-B (CCK-B)/gastrin receptor targeting peptides for staging and therapy of medullary thyroid cancer and other CCK-B receptor expressing malignancies.
Topics: Animals; Gastrins; Humans; Ligands; Mice; Pentetic Acid; Peptides; Radiopharmaceuticals; Receptor, C | 2002 |
111In-octreotide and 99mTc(V)-dimercaptosuccinic acid studies in the imaging of recurrent medullary thyroid carcinoma.
Topics: Adult; Biomarkers, Tumor; Calcitonin; Carcinoma, Medullary; Female; Humans; Male; Middle Aged; Neopl | 1995 |
[Somatostatin receptor scintigraphy in medullary thyroid carcinomas, GEP and carcinoid tumors].
Topics: Adult; Aged; Calcitonin; Carcinoembryonic Antigen; Carcinoid Tumor; Carcinoma, Medullary; False Posi | 1995 |
Indium-111 activity concentration in tissue samples after intravenous injection of indium-111-DTPA-D-Phe-1-octreotide.
Topics: Abdominal Neoplasms; Adult; Aged; Carcinoid Tumor; Chronic Disease; Female; Humans; Indium Radioisot | 1995 |
The contribution of somatostatin receptor scintigraphy to the diagnosis of recurrent medullary carcinoma of the thyroid.
Topics: Adolescent; Adult; Aged; Calcitonin; Carcinoma, Medullary; Female; Gene Expression Regulation, Neopl | 1994 |
Biodistribution of 111In-pentetreotide and dosimetric considerations with respect to somatostatin receptor expressing tumor burden.
Topics: Biomarkers, Tumor; Gastrointestinal Neoplasms; Humans; Indium Radioisotopes; Octreotide; Pancreatic | 1993 |
Somatostatin receptor scintigraphy and magnetic resonance imaging in recurrent medullary thyroid carcinoma: a comparative study.
Topics: Adolescent; Adult; Aged; Biomarkers, Tumor; Carcinoma; Female; Humans; Indium Radioisotopes; Magneti | 1993 |
Distribution and elimination of the somatostatin analogue (111In-DTPA-D-Phe1)-Octreotide (OctreoScan111).
Topics: Adenoma, Islet Cell; Adult; Aged; Carcinoid Tumor; Chromatography, Gel; Endocrine Gland Neoplasms; F | 1993 |
Octreotide scintigraphy in patients with differentiated thyroid carcinoma: contribution for patients with negative radioiodine scan.
Topics: Adult; Aged; Aged, 80 and over; Female; Humans; Indium Radioisotopes; Iodine Radioisotopes; Lymphati | 1996 |
Cost-effectiveness analysis of somatostatin receptor scintigraphy.
Topics: Carcinoid Tumor; Carcinoma, Medullary; Carcinoma, Small Cell; Cost-Benefit Analysis; Costs and Cost | 1996 |
Comparison of octreotide scintigraphy and conventional imaging in medullary thyroid carcinoma.
Topics: Adult; Aged; Carcinoma, Medullary; Female; Humans; Indium Radioisotopes; Liver Neoplasms; Male; Midd | 1996 |
Gadolinium-enhanced MR imaging of thyroid and parathyroid masses.
Topics: Adenoma; Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma, Papillary; Contrast Media; Drug Comb | 1997 |
Somatostatin receptor scintigraphy in medullary thyroid carcinoma.
Topics: Blotting, Northern; Female; Humans; Immunohistochemistry; Lymphatic Metastasis; Male; Middle Aged; M | 1997 |
Octreotide uptake in the head and neck.
Topics: Carcinoma, Medullary; Diagnosis, Differential; Female; Head and Neck Neoplasms; Humans; Indium Radio | 1997 |
[Value of scintigraphic explorations by radiomarkers others than iodine radioisotope in differentiated thyroid cancer].
Topics: Adenocarcinoma; Carcinoma, Papillary; Deoxyglucose; Fluorodeoxyglucose F18; Humans; Iodine Radioisot | 1997 |
Thoracic and abdominal SPECT-CT image fusion without external markers in endocrine carcinomas. The Group of Thyroid Tumoral Pathology of Champagne-Ardenne.
Topics: 3-Iodobenzylguanidine; Abdominal Neoplasms; Carcinoid Tumor; Carcinoma, Medullary; Feasibility Studi | 1997 |
New research developments increase therapeutic options for thyroid cancer and bone pain palliation.
Topics: Analgesics, Non-Narcotic; Bone Neoplasms; Female; Humans; Iodine Radioisotopes; Isotopes; Male; Orga | 1997 |
Somatostatin receptor scintigraphy using [111In-DTPA0]RC-160 in humans: a comparison with [111In-DTPA0]octreotide.
Topics: Adenocarcinoma, Follicular; Adult; Carcinoma, Medullary; Female; Humans; Indium Radioisotopes; Insul | 1998 |
Somatostatin receptor expression in Hürthle cell cancer of the thyroid.
Topics: Adenoma, Oxyphilic; Aged; Humans; Indium Radioisotopes; Male; Middle Aged; Octreotide; Pentetic Acid | 1998 |
Internalization of radiolabelled [DTPA0]octreotide and [DOTA0,Tyr3]octreotide: peptides for somatostatin receptor-targeted scintigraphy and radionuclide therapy.
Topics: Animals; Binding, Competitive; Biological Transport; Carcinoma; Cell Line; Humans; Indium Radioisoto | 1998 |
Localization of neuroendocrine tumours with [111In] DTPA-octreotide scintigraphy (Octreoscan): a comparative study with CT and MR imaging.
Topics: Adolescent; Adult; Aged; Carcinoid Tumor; Carcinoma, Medullary; Child; Female; Humans; Indium Radioi | 1998 |
Indium-111-DTPA-D-Phe-1-octreotide and technetium-99m-(V)-dimercaptosuccinic acid scanning in the preoperative staging of medullary thyroid carcinoma.
Topics: Carcinoma, Medullary; Female; Humans; Indium Radioisotopes; Lymph Nodes; Lymphatic Metastasis; Male; | 1998 |
Bispecific antibody and bivalent hapten radioimmunotherapy in CEA-producing medullary thyroid cancer xenograft.
Topics: Animals; Antibodies, Bispecific; Antibodies, Monoclonal; Carcinoembryonic Antigen; Carcinoma, Medull | 1999 |
Expression of somatostatin receptors in oncocytic (Hürthle cell) neoplasia of the thyroid.
Topics: Adenoma, Oxyphilic; Adult; Aged; Aged, 80 and over; Blotting, Northern; Female; Humans; Indium Radio | 1999 |
Toxicity and efficacy of radioimmunotherapy in carcinoembryonic antigen-producing medullary thyroid cancer xenograft: comparison of iodine 131-labeled F(ab')2 and pretargeted bivalent hapten and evaluation of repeated injections.
Topics: Animals; Carcinoembryonic Antigen; Carcinoma, Medullary; Haptens; Humans; Immunoglobulin Fab Fragmen | 1999 |
111In-DTPA-D-Phe1-octreotide binding and somatostatin receptor subtypes in thyroid tumors.
Topics: Blotting, Northern; Humans; Indium Radioisotopes; Lymphatic Metastasis; Octreotide; Pentetic Acid; R | 2000 |
Cholecystokinin receptor imaging using an octapeptide DTPA-CCK analogue in patients with medullary thyroid carcinoma.
Topics: Carcinoma, Medullary; Humans; Indium Radioisotopes; Pentetic Acid; Radionuclide Imaging; Receptor, C | 2000 |
[The scintigraphy of somatostatin receptors in the carcinoid tumor].
Topics: Adult; Aged; Bone Neoplasms; Brain Neoplasms; Carcinoid Tumor; Diagnosis, Differential; Digestive Sy | 2001 |
An unusual case of a false-positive iodine-131 whole body scan in a patient with papillary thyroid cancer.
Topics: Aged; Barium Sulfate; Carcinoma, Papillary; Colon; Esophageal Neoplasms; Esophagus; False Positive R | 1988 |
Radioimmunoscintigraphy with anti-thyroglobulin monoclonal antibodies.
Topics: Animals; Antibodies, Monoclonal; Carcinoma, Papillary; Humans; Indium; Mice; Mice, Nude; Neoplasm Tr | 1986 |